Your browser doesn't support javascript.
loading
Barriers and enablers to people-centred viral hepatitis care in Vietnam and the Philippines: Results of a patient journey mapping study.
Holt, Bethany; Mendoza, Jhaki; Nguyen, Hoang; Doan, Duong; Nguyen, Vy H; Cabauatan, Daniel Joy; Duy, Lam Dam; Fernandez, Martin; Gaspar, Manu; Hamoy, Geohari; Manlutac, Joseph Michael D; Mehtsun, Sinit; Mercado, Timothy Bill; Neo, Boon-Leong; Le, Bao Ngoc; Nguyen, Hoa; Nguyen, Huyen Thu; Nguyen, Yen; Pham, Thuy; Pollack, Todd; Rombaoa, Mary Cris; Thai, Pham; Thu, Tran Khanh; Truong, Pham Xuan; Vu, Dung; Ong, Janus; Duong, David.
Afiliación
  • Holt B; Program in Global Primary Care and Social Change, Harvard Medical School, Boston, Massachusetts, USA.
  • Mendoza J; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Nguyen H; National Institutes of Health, University of the Philippines, Manila, Philippines.
  • Doan D; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.
  • Nguyen VH; Hanoi University of Public Health, Hanoi, Vietnam.
  • Cabauatan DJ; Program in Global Primary Care and Social Change, Harvard Medical School, Boston, Massachusetts, USA.
  • Duy LD; National Institutes of Health, University of the Philippines, Manila, Philippines.
  • Fernandez M; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.
  • Gaspar M; National Institutes of Health, University of the Philippines, Manila, Philippines.
  • Hamoy G; National Institutes of Health, University of the Philippines, Manila, Philippines.
  • Manlutac JMD; National Institutes of Health, University of the Philippines, Manila, Philippines.
  • Mehtsun S; Department of Health, Central Luzon Center for Health Development, Pampanga, Philippines.
  • Mercado TB; Global Patient Solutions, Gilead Science, Washington, DC, USA.
  • Neo BL; Global Patient Solutions, Gilead Science, Singapore, Singapore.
  • Le BN; National Institutes of Health, University of the Philippines, Manila, Philippines.
  • Nguyen H; Global Patient Solutions, Gilead Science, Washington, DC, USA.
  • Nguyen HT; Global Patient Solutions, Gilead Science, Singapore, Singapore.
  • Nguyen Y; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.
  • Pham T; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.
  • Pollack T; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.
  • Rombaoa MC; Action to the Community Development Institute, Hanoi, Vietnam.
  • Thai P; The Partnership for Health Advancement in Vietnam (HAIVN), Hanoi, Vietnam.
  • Thu TK; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Truong PX; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Vu D; School of Health Sciences, University of the Philippines Manila, Tarlac, Philippines.
  • Ong J; Department of Health, Thai Binh, Vietnam.
  • Duong D; Department of Health, Thai Binh, Vietnam.
J Viral Hepat ; 31(7): 391-403, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38654623
ABSTRACT
In Vietnam and the Philippines, viral hepatitis is the leading cause of cirrhosis and liver cancer. This study aims to understand the barriers and enablers of people receiving care for hepatitis B and C to support both countries' efforts to eliminate viral hepatitis as a public health threat by 2030. Retrospective, semi-structured interviews were conducted with a purposive, quota-based sample of 63 people living with hepatitis B or C in one province of Vietnam and one region of the Philippines. A rapid deductive approach to thematic analysis produced key findings among the three phases of care (1) pre-awareness and testing, (2) linkage and treatment initiation and (3) ongoing treatment and recovery. The research found that participants followed five typical journeys, from a variety of entry points. Barriers during the pre-awareness and testing phase included limited awareness about hepatitis and its management, stigma and psychological impacts. Enablers included being familiar with the health system and/or patients benefiting from social connections within the health systems. During the linkage and treatment initiation phase, barriers included difficult physical access, complex navigation and inadequate counselling. In this phase, family support emerged as a critical enabler. During the ongoing treatment and recovery phase, the cost of care and socially and culturally informed perceptions of the disease and medication use were both barriers and enablers. Exploring peoples' journeys with hepatitis B and C in Vietnam and the Philippines revealed many similarities despite the different cultural and health system contexts. Insights from this study may help generate a contextualized, people-centred evidence base to inform the design and improvement of primary care services for hepatitis in both research sites.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Accesibilidad a los Servicios de Salud Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Accesibilidad a los Servicios de Salud Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article